MetLife (NYSE:MET – Get Free Report) will likely be releasing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect MetLife to announce earnings of $2.30 per share and revenue of $19.6652 billion for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 9:00 AM ET.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.15. The business had revenue of $14.18 billion during the quarter, compared to the consensus estimate of $19.49 billion. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.96 earnings per share. On average, analysts expect MetLife to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.
MetLife Stock Up 2.6%
MET opened at $97.65 on Wednesday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.53. The stock has a market cap of $62.83 billion, a price-to-earnings ratio of 18.92, a PEG ratio of 0.73 and a beta of 0.78. MetLife has a twelve month low of $67.33 and a twelve month high of $97.69. The company’s 50-day moving average price is $87.88 and its two-hundred day moving average price is $79.77.
MetLife Dividend Announcement
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in MET. Invesco Ltd. grew its holdings in MetLife by 2.6% during the 4th quarter. Invesco Ltd. now owns 7,012,198 shares of the financial services provider’s stock valued at $553,543,000 after buying an additional 176,811 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in MetLife by 2.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,201,175 shares of the financial services provider’s stock worth $410,581,000 after purchasing an additional 126,098 shares in the last quarter. AQR Capital Management LLC boosted its holdings in MetLife by 105.3% in the 3rd quarter. AQR Capital Management LLC now owns 3,305,620 shares of the financial services provider’s stock valued at $271,424,000 after purchasing an additional 1,695,563 shares during the period. Stifel Financial Corp grew its position in shares of MetLife by 1.2% during the 4th quarter. Stifel Financial Corp now owns 2,660,727 shares of the financial services provider’s stock valued at $210,038,000 after purchasing an additional 32,554 shares in the last quarter. Finally, Deutsche Bank AG grew its position in shares of MetLife by 47.9% during the 4th quarter. Deutsche Bank AG now owns 2,569,444 shares of the financial services provider’s stock valued at $202,832,000 after purchasing an additional 831,986 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently commented on MET. UBS Group upped their price objective on MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Wells Fargo & Company raised their target price on MetLife from $95.00 to $101.00 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. Morgan Stanley upped their price target on MetLife from $93.00 to $103.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. Jefferies Financial Group increased their price target on MetLife from $97.00 to $103.00 and gave the stock a “buy” rating in a research note on Friday, July 10th. Finally, JPMorgan Chase & Co. lifted their price objective on MetLife from $96.00 to $106.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $100.50.
Read Our Latest Research Report on MET
About MetLife
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Read More
- Five stocks we like better than MetLife
- Welltower at 52-Week Highs—But Analysts Believe There’s More to Come
- D-Wave’s AT&T Deal Shows Quantum Computing Is Moving Beyond Theory
- Insiders Sell, Institutions Buy: The AI Trade Is Getting More Interesting
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
